These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 16307669)

  • 21. A case of cutaneous leiomyosarcoma with overexpression of KIT: do CD117 (KIT)-positive primary gastrointestinal stromal tumours of the skin exist?
    Horie M; Hatamochi A; Yamazaki S; Izumi M; Mukai K
    Br J Dermatol; 2006 May; 154(5):1013-6. PubMed ID: 16634920
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunohistochemical staining for p63 is useful in the diagnosis of anal squamous cell carcinomas.
    Owens SR; Greenson JK
    Am J Surg Pathol; 2007 Feb; 31(2):285-90. PubMed ID: 17255774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Expression of deltaNp63 in salivary gland tumours].
    He ZX; Li YN; Liu LK; He HW; Wang D
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 37(1):126-8. PubMed ID: 16468660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The p53-homologue p63 may promote thyroid cancer progression.
    Malaguarnera R; Mandarino A; Mazzon E; Vella V; Gangemi P; Vancheri C; Vigneri P; Aloisi A; Vigneri R; Frasca F
    Endocr Relat Cancer; 2005 Dec; 12(4):953-71. PubMed ID: 16322335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased expression of the p63 related proteins beta-catenin, E-cadherin and EGFR in oral lichen planus.
    Ebrahimi M; Boldrup L; Wahlin YB; Coates PJ; Nylander K
    Oral Oncol; 2008 Jul; 44(7):634-8. PubMed ID: 17936670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Actin and calponin expression in basal cell carcinoma.
    Lee MW; Ahn SJ; Choi JH; Moon KC; Koh JK
    Br J Dermatol; 2004 Oct; 151(4):934-6. PubMed ID: 15491449
    [No Abstract]   [Full Text] [Related]  

  • 27. Antibodies targeting p63 react specifically in the cytoplasm of breast epithelial cells exhibiting secretory differentiation.
    Bratthauer GL; Saenger JS; Strauss BL
    Histopathology; 2005 Dec; 47(6):611-6. PubMed ID: 16324199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TA-p63-gamma regulates expression of DeltaN-p63 in a manner that is sensitive to p53.
    Li N; Li H; Cherukuri P; Farzan S; Harmes DC; DiRenzo J
    Oncogene; 2006 Apr; 25(16):2349-59. PubMed ID: 16331262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p63 is useful in the diagnosis of mammary metaplastic carcinomas.
    Tse GM; Tan PH; Chaiwun B; Putti TC; Lui PC; Tsang AK; Wong FC; Lo AW
    Pathology; 2006 Feb; 38(1):16-20. PubMed ID: 16484002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p63 expression correlates with pathological features and biological behaviour of odontogenic tumours.
    Lo Muzio L; Santarelli A; Caltabiano R; Rubini C; Pieramici T; Giannone N; Carinci F; Leonardi R; Lanzafame S; Piattelli A
    Histopathology; 2006 Aug; 49(2):211-4. PubMed ID: 16879406
    [No Abstract]   [Full Text] [Related]  

  • 31. DeltaNp63 isoforms regulate CD44 and keratins 4, 6, 14 and 19 in squamous cell carcinoma of head and neck.
    Boldrup L; Coates PJ; Gu X; Nylander K
    J Pathol; 2007 Dec; 213(4):384-91. PubMed ID: 17935121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p63 in prostate biology and pathology.
    Grisanzio C; Signoretti S
    J Cell Biochem; 2008 Apr; 103(5):1354-68. PubMed ID: 17879953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationships between p63 binding, DNA sequence, transcription activity, and biological function in human cells.
    Yang A; Zhu Z; Kapranov P; McKeon F; Church GM; Gingeras TR; Struhl K
    Mol Cell; 2006 Nov; 24(4):593-602. PubMed ID: 17188034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p63: defining roles in morphogenesis, homeostasis, and neoplasia of the epidermis.
    King KE; Weinberg WC
    Mol Carcinog; 2007 Aug; 46(8):716-24. PubMed ID: 17477357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p63(TP63) elicits strong trans-activation of the MFG-E8/lactadherin/BA46 gene through interactions between the TA and DeltaN isoforms.
    Okuyama T; Kurata S; Tomimori Y; Fukunishi N; Sato S; Osada M; Tsukinoki K; Jin HF; Yamashita A; Ito M; Kobayashi S; Hata RI; Ikawa Y; Katoh I
    Oncogene; 2008 Jan; 27(3):308-17. PubMed ID: 17637751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemistry of p63 in primary and secondary vulvar Paget's disease.
    Yanai H; Takahashi N; Omori M; Oda W; Yamadori I; Takada S; Matsuura H; Yoshino T
    Pathol Int; 2008 Oct; 58(10):648-51. PubMed ID: 18801085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic impact of p53 and p63 immunoexpression in oral squamous cell carcinoma.
    de Oliveira LR; Ribeiro-Silva A; Zucoloto S
    J Oral Pathol Med; 2007 Apr; 36(4):191-7. PubMed ID: 17391296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of p63 leads to increased cell migration and up-regulation of genes involved in invasion and metastasis.
    Barbieri CE; Tang LJ; Brown KA; Pietenpol JA
    Cancer Res; 2006 Aug; 66(15):7589-97. PubMed ID: 16885358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Double immunostaining with p63 and high-molecular-weight cytokeratins distinguishes borderline papillary lesions of the breast.
    Ichihara S; Fujimoto T; Hashimoto K; Moritani S; Hasegawa M; Yokoi T
    Pathol Int; 2007 Mar; 57(3):126-32. PubMed ID: 17295644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of vitamin D receptor as a target of p63.
    Kommagani R; Caserta TM; Kadakia MP
    Oncogene; 2006 Jun; 25(26):3745-51. PubMed ID: 16462763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.